Nurse Practitioner · Andover, MA
NPI
1760977441
Since 2018
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
323 Lowell St
Andover, MA, 01812
Phone (888) 227-3762
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,120
111 services
Medicare patients, 2024
57
Average age 72
Drug cost, 2024
$5.1M
49,175 prescriptions
Company payments, 2025
$139
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen P Bravo Sosa was code 99214 (office e&m - established), 63 times for 46 patients. In total Karen P Bravo Sosa billed 111 services in 20 codes, and Medicare paid $7,120.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 63 | 46 | $66.43 | $4,185 |
| 99213 Office E&M - Established | Office | 11 | 11 | $52.73 | $580 |
By year: 2022 $4,799 for 99 services; 2023 $5,885 for 88 services; 2024 $7,120 for 111 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 14 | $2.96 | $50.37 |
Medicare prescription drug claims, 2024
In 2024, the drug Karen P Bravo Sosa prescribed most often to Medicare patients was Atorvastatin Calcium, with 4,057 prescriptions and refills. In total Karen P Bravo Sosa wrote 49,175 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 4,057 | 10,998 | 1,464 | $52K |
| Lisinopril Generic | 2,606 | 7,106 | 1,008 | $20K |
| Amlodipine Besylate Generic | 2,359 | 6,495 | 872 | $17K |
| Omeprazole Generic | 2,299 | 5,989 | 802 | $45K |
| Levothyroxine Sodium Generic | 2,249 | 6,070 | 848 | $22K |
| Simvastatin Generic | 1,455 | 4,006 | 530 | $13K |
| Metoprolol Succinate Generic | 1,451 | 3,797 | 495 | $24K |
| Losartan Potassium Generic | 1,421 | 3,902 | 540 | $14K |
| Rosuvastatin Calcium Generic | 1,231 | 3,437 | 468 | $31K |
| Hydrochlorothiazide Generic | 1,076 | 3,133 | 441 | $5,133 |
| Metformin Hcl Generic | 1,043 | 2,725 | 387 | $8,801 |
| Metformin Hcl Er Metformin Hcl | 809 | 2,162 | 312 | $10K |
| Sertraline Hcl Generic | 799 | 2,217 | 311 | $7,111 |
| Gabapentin Generic | 774 | 1,668 | 333 | $17K |
| Atenolol Generic | 773 | 2,220 | 291 | $7,271 |
Brand drugs: 5,618 claims; generic drugs: 43,106 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen P Bravo Sosa $139 ($139 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $139.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.